F23-9340161-7/100002/1

Glaxo Operations U.K. Ltd. — FEI 3002807078

Refusal Details

Date
September 3, 2025
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
58MCY20 BELIMUMAB
Charges
75